Shares of Array Biopharma Inc ARRY, a biopharmaceutical company that focuses on drugs to treat patients suffering from cancer, lost more than 12 percent early Monday morning after announcing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback